Tectonic Therapeutic Inc. (TECX)

Tectonic Therapeutic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	98.3	92.85	189.57	260.17	187.54
Cash & Cash Equivalents	98.3	92.85	189.57	260.17	187.54
Cash Growth	5.88%	-51.02%	-27.14%	38.73%	48.48%
Other Current Assets	1.96	7.11	9.58	7.07	8.17
Total Current Assets	100.26	99.96	199.15	267.24	195.7
Property, Plant & Equipment	0.43	3.95	4.13	3.06	3.7
Long-Term Investments	0.4	0	0.49	0	0
Other Long-Term Assets	0	0.04	0.07	0.93	1.12
Total Long-Term Assets	0.83	3.99	4.69	3.99	4.81
Total Assets	101.09	103.95	203.84	271.23	200.51
Accounts Payable	0.03	0.38	3.49	2.68	3.95
Current Debt	0.88	1	0	0	0
Other Current Liabilities	5.45	11.73	15.9	13.93	10.07
Total Current Liabilities	6.35	13.12	19.39	16.61	14.02
Long-Term Debt	0	15.46	14.95	0	0
Other Long-Term Liabilities	0	0	0.03	0.28	0.48
Total Long-Term Liabilities	0	15.46	14.98	0.28	0.48
Total Liabilities	6.35	28.58	34.36	16.89	14.5
Total Debt	0.88	16.46	14.95	0	0
Debt Growth	-94.67%	10.16%	-	-	-
Retained Earnings	-477.28	-489.43	-383.54	-264.42	-144.7
Shareholders' Equity	94.74	75.37	169.48	254.34	186.01
Net Cash / Debt	97.43	76.38	174.62	260.17	187.54
Net Cash / Debt Growth	27.55%	-56.26%	-32.88%	38.73%	48.48%
Net Cash Per Share	26.23	20.96	48.90	86.23	82.04
Working Capital	93.91	86.84	179.76	250.63	181.68
Book Value Per Share	25.65	20.68	47.46	84.30	81.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).